Treatment Resistant Depression Clinical Trials in Toronto, Ontario
6 recruitingToronto, Ontario, Canada
Showing 1–6 of 6 trials
Recruiting
Phase 1
Psilocybin for Treatment-Resistant Depression in Autism
Autism Spectrum DisorderTreatment Resistant Depression
Centre for Addiction and Mental Health20 enrolled1 locationNCT06731621
Recruiting
Characterizing Dopamine Receptor Binding in Treatment Resistant Depression
Treatment Resistant Depression
Unity Health Toronto45 enrolled1 locationNCT03537794
Recruiting
Phase 2
i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial
SuicideMajor Depressive DisorderTreatment Resistant Depression
University Health Network, Toronto110 enrolled1 locationNCT06480500
Recruiting
Phase 2
Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)
Treatment Resistant Depression
Centre for Addiction and Mental Health12 enrolled1 locationNCT06512220
Recruiting
Phase 2
Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)
Chronic PainTreatment Resistant Depression
Centre for Addiction and Mental Health16 enrolled1 locationNCT06518720
Recruiting
Not Applicable
The Impact of Working Memory and Reward Markers on DLPFC Activity in Treatment-resistant Depression
Major Depressive DisorderTreatment Resistant Depression
Unity Health Toronto50 enrolled1 locationNCT06163625